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DC-SIGN ligation on dendritic cells results in ERK and PI3K activation
and modulates cytokine production
Esther Caparro´s, Pilar Munoz, Elena Sierra-Filardi, Diego Serrano-Go´mez, Amaya Puig-Kro¨ger, Jose´ L. Rodrı´guez-Ferna´ndez,
Mario Mellado, Jaime Sancho, Mercedes Zubiaur, and Angel L. Corbı´
The generation of pathogen-specific im-
mune responses is dependent on the sig-
naling capabilities of pathogen-recognition
receptors. DC-SIGN is a C-type lectin that
mediates capture and internalization of vi-
ral, bacterial, and fungal pathogens by my-
eloid dendritic cells. DC-SIGN–interacting
pathogens are thought to modulate den-
dritic cell maturation by interfering with intra-
cellular signaling from Toll-like receptor mol-
ecules. We report that engagement of DC-
SIGN by specific antibodies does not
promote dendritic cell maturation but in-
duces ERK1/2 and Akt phosphorylation
without concomitant p38MAPK activa-
tion. DC-SIGN ligation also triggers PLC
phosphorylation and transient increases
in intracellular calcium in dendritic cells.
In agreement with its signaling capabili-
ties, a fraction of DC-SIGN molecules
partitions within lipid raft–enriched mem-
brane fractions both in DC-SIGN–trans-
fected and dendritic cells. Moreover, DC-
SIGN in dendritic cells coprecipitates with
the tyrosine kinases Lyn and Syk. The
relevance of the DC-SIGN–initiated sig-
nals was demonstrated in monocyte-
derived dendritic cells, as DC-SIGN cross-
linking synergizes with TNF- for IL-10
release and enhances the production of
LPS-induced IL-10. These results demon-
strate that DC-SIGN–triggered intracellu-
lar signals modulate dendritic cell matura-
tion. Since pathogens stimulate Th2
responses via preferential activation of
ERK1/2, these results provide a molecu-
lar explanation for the ability of DC-SIGN–
interacting pathogens to preferentially
evoke Th2-type immune responses.
(Blood. 2006;107:3950-3958)
© 2006 by The American Society of Hematology
Introduction
The functional consequences of the dendritic cell (DC)–T lympho-
cyte interactions are critically dependent on the maturation state of
the DC.1 In the steady state, immature DCs capture and process
antigens and promote either deletion of self-specific T cells or the
generation and expansion of regulatory T cells, thus resulting in
tolerance and preventing autoimmune responses. By contrast, in
the presence of pathogens, DCs acquire the capacity to initiate
potent immune responses (DC maturation).2 Pathogen recognition
is accomplished by pathogen-associated molecular patterns (PAMPs)
receptors, which include members of the Toll-like receptor (TLR)
and lectin protein families3 and endow DCs with the ability to
respond to exogenous agents and microbes.
The DC maturation program exhibits a huge degree of plastic-
ity, thus allowing the generation of pathogen-tailored immune
responses. Indeed, gene expression profile analysis of DCs exposed
to pathogens or pathogen-derived products has confirmed that DC
maturation is pathogen specific.4 The intracellular signaling path-
ways that regulate DC maturation are beginning to be unraveled. In
the case of TLR ligands, activation of NF-B is an absolute
requirement for DC maturation,5 but the modulation of NF-B–
dependent gene transcription by other signaling routes contributes
to the generation of pathogen-specific responses.6 As an example,
the differential ability of maturation-inducing agents to promote
IL-12p70 release depends on their distinct capacity to activate
p38MAPK, which “conditions” the IL-12p35 regulatory region for
NF-B occupancy.7 Unlike p38MAPK, activation of the MEK-
ERK signaling axis impairs the acquisition of maturation parame-
ters,8 and PI3K activation also modulates NF-B–induced den-
dritic cell maturation.9 Comparison of the intracellular signals from
TLR4 and TLR2 has recently suggested that TLR agonists differen-
tially instruct dendritic cells to initiate Th responses via modulation
of intracellular signaling pathways10: TLR4 ligation favors pro-Th1
dendritic cell maturation through the p38MAPK-dependent synthe-
sis of IL-12p70, whereas TLR2 ligands stimulate Th2 responses via
preferential activation of ERK1/2 and c-fos.11
DCs display a large array of cell surface lectins and lectinlike
molecules whose contribution to the maturation program is not
completely understood. DC-SIGN is a C-type lectin implicated in
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capture and uptake of viral (HIV, hepatitis C virus [HCV], Ebola,
dengue), bacterial, fungal, and parasite pathogens by DCs.3,12 Most
DC-SIGN–interacting microbes elicit Th2-type responses that
result in impaired pathogen clearance and the establishment of
chronic infections. This has led to the proposal that pathogens
subvert DC-SIGN functions as a means to avoid immunosurveil-
lance and the generation of effective immune responses.3,12 In this
regard, the shift of the immune responses toward Th2 caused by
Mycobacterium tuberculosis appears to depend on lipoarabinoman-
nan, which increases IL-10 release from DCs by interacting with
DC-SIGN.12 Therefore, the determination of DC-SIGN–initiated
intracellular signals might facilitate the development of therapeutic
strategies against the pathogens recognized by this lectin. We now
present evidence that DC-SIGN ligation triggers activation of PI3K
and ERK1/2, and a rapid and transient increase in intracellular
calcium mobilization, in both dendritic cells and transfected cells,
and that DC-SIGN colocalizes with protein tyrosine kinases in
specialized membrane microdomains. The functional relevance of
these intracellular signals is illustrated by the enhanced release of
IL-10 observed in maturing dendritic cells upon DC-SIGN cross-
linking. These results demonstrate that DC-SIGN–triggered intra-
cellular signals modulate dendritic cell maturation and provide a
molecular explanation for the ability of DC-SIGN–interacting
pathogens to preferentially provoke Th2-type immune responses.
Materials and methods
Cell culture
Human peripheral blood mononuclear cells (PBMCs) were isolated from
buffy coats from healthy donors over a Lymphoprep (Nycomed Pharma,
Oslo, Norway) gradient according to standard procedures. Monocytes were
purified from PBMCs by a 1-hour adherence step at 37°C in complete
medium or by magnetic cell sorting using CD14 microbeads (Miltenyi
Biotech, Bergisch Gladbach, Germany). To generate monocyte-derived
dendritic cells (MDDCs), adherent or CD14 cells ( 95% monocytes)
were cultured at 0.5 to 1  106 cells/mL in RPMI with 10% fetal calf serum
(FCS), 25 mM HEPES, and 2 mM glutamine (complete medium), at 37°C
in a humidified atmosphere with 5% CO2. Complete medium was supple-
mented with 1000 U/mL granulocyte-macrophage–colony-stimulating fac-
tor (GM-CSF, Leucomax; Schering-Plough, Kenilworth, NJ) and 1000 U/mL
IL-4 (PreProtech, Rocky Hill, NJ) for 5 to 7 days, with cytokine addition
every second day. MDDC maturation was induced with either TNF-
(20 ng/mL; Peprotech EC, London, England), ultrapure LPS from Esche-
richia coli 0111:B4 (10 ng/mL), or Pam3Cys (20 g/mL; InvivoGen, San
Diego, CA). The human cell lines Jurkat (T-cell lymphoma) and THP-1
(monocytic leukemia) were cultured in complete medium. DC-SIGN–
expressing Jurkat cells (Jurkat-DC-SIGN) were generated after electropora-
tion of the pCDNA3-DC-SIGN plasmid,13 selection in complete medium
with 600 g/mL G418 (Gibco, Grand Island, NY), and cell sorting with the
MR-1 antibody. A similar procedure was done to generate Jurkat-mock
cells, which are stably transfected with an empty pCDNA3.1() vector.
Cells were observed under a Zeiss Axiovert 25 microscope equipped with a
32 /0.4 Ph1 lens (Zeiss, Jena, Germany), and were photographed with a
RICOH XR-X3000 camera (Ricoh, West Caldwell, NJ). Image acquisition
was performed with Dell photographic editor software in the Dell AIO
printer (Dell, Round Rock, TX); subsequent processing was done with
Adobe Photoshop 7.0 software (Adobe Systems, San Jose, CA).
Flow cytometry and antibodies
Phenotypic analysis of MDDCs and cell lines was carried out by immuno-
fluorescence. Monoclonal antibodies used for cell surface staining included
phycoerythrin-labeled anti-CD83 (BD Biosciences, San Diego, CA), FITC-
FA6-152 (anti-CD36; Immunotech, Marseille, France), and MR1 (anti–DC-
SIGN, CD209).13 In this case, incubation with the unlabeled primary
antibody was followed by incubation with FITC-labeled F(ab)2 goat
anti–mouse IgG. All incubations were done in the presence of 50 g/mL
human IgG to prevent binding through the Fc portion of the antibodies.
P3X63 myeloma supernatant was included as negative control, and flow
cytometry analysis was performed with an EPICS-CS (Coulter, Madrid,
Spain) using log amplifiers.
Determination of IL-10 levels
Immature MDDCs (106/mL complete medium) were treated with maturing
agents (LPS at 10 ng/mL, Pam3Cys at 20 g/mL, or TNF- at 20 ng/mL)
and either in the absence or presence of purified antibody against DC-SIGN
(MR-1) or purified mouse IgG as control. After 18 hours, cell supernatants
were collected and IL-10 levels determined using the IL-10 ELISA Set
(Immunotools, Friesoythe, Germany) following the manufacturer’s recom-
mendations. MDDC supernatants were assayed undiluted and diluted 1:3 in
complete medium.
DC-SIGN cross-linking experiments
MDDCs or Jurkat cells were washed extensively in RPMI and cultured in
RPMI containing 0.5% FCS to reduce the basal level of activation.
Preliminary experiments indicated that MDDCs cultured overnight in
RPMI 0.5% FCS exhibited a low level of ERK phosphorylation, whereas
Jurkat cells required a 24/36-hour culture period. Then cells were trans-
ferred to a 37°C water bath and treated with the stimulatory agents for
5 minutes or the indicated period of time. In all cases, 2  106 MDDCs or
Jurkat cells was used for each experimental condition. Stimulatory antibod-
ies were added at 20 g/mL, and included purified monoclonal antibodies
against DC-SIGN (MR-1),13 CD38 (HB136), CD70 (qa32), CD11c (HC1/
1), and c-Myc (9E10). As positive control, cells were treated with either
TNF- (20 ng/mL), PMA (10 ng/mL), or a monoclonal antibody against
CD3 at 20 g/mL (OKT3). In some experiments, negative controls also
included purified human IgG (AP3D11). After stimulation, cells were
immediately lysed with 2  lysis buffer (40 mM HEPES [pH 7.6], 300 mM
NaCl, 2 mM EGTA, 1% NP-40, 100 M phenylarsine oxide, 100 mM NaF,
2 mM Na3VO4, 2 mM Pefabloc, 20 mM iodoacetamide, and 2 g/mL
aprotinin, antipain, leupeptin, and pepstatin), and cell lysates subjected to
Western blot with antibodies specific for the activated/phosphorylated
forms of various signaling pathways.
Western blot
Cell lysates (10 g) were subjected to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions
and transferred onto an Immobilon polyvinylidene difluoride membrane
(PVDF; Millipore, Bedford, MA). After blocking with 1% BSA in 50 mM
Tris-HCl (pH 7.6), 150 mM NaCl, 0.1% Tween-20, protein detection was
performed using the Supersignal West Pico Chemiluminescent system
(Pierce, Rockford, IL). For reprobing, membranes were incubated in
stripping buffer (62.5 mM Tris-HCl [pH 6.7], 100 mM 	-mercaptoethanol,
2% SDS) for 30 minutes at 50°C with occasional agitation. Detection of
phosphotyrosine, phospho-p38MAPK, phospho-PI3K, phospho-PLC
, phos-
pho-ERK, and phospho-ZAP70 was carried out using polyclonal antibodies
specific for antiphosphotyrosine (RC20-HRP; BD Biosciences), anti–
phospho-p38MAPK (T180/Y182, no. 9211; Cell Signaling Technology,
Beverly, MA), anti–phospho-Akt (no. 9271; Cell Signaling Technology),
anti–phospho-PLC
 (sc-12943; Santa Cruz Biotechnology, Santa Cruz,
CA), anti–phospho-ZAP70 (Y493, no. 9212; Cell Signaling Technology),
and a monoclonal antibody anti–phospho-p44/42 MAPK (T202-Y204, no.
9101; Cell Signaling Technology). As a control for protein loading, blots
were reprobed with polyclonal antisera against ERK (no. 9102; Cell
Signaling Technology), p38MAPK (no. 9212; Cell Signaling Technology),
PLC
 (sc-423; Santa Cruz Biotechnology), or tubulin (clone DM 1A;
Sigma, Barcelona, Spain).
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Isolation of detergent-insoluble and -soluble cell membrane
fractions by sucrose gradient ultracentrifugation
and membrane distribution of DC-SIGN
Detergent solubilization of cells (7-9  107) at 37°C with 1% Brij 98
(Sigma Aldrich, St Louis, MO) was carried out as described.14 Cell lysates
were mixed with an equal volume of 80% sucrose and transferred to Sorvall
ultracentrifuge tubes (Sorvall, Asheville, NC). The following were overlaid:
2 mL 30% sucrose, followed by 1 mL 5% sucrose in 20 mM HEPES (pH
7.6), 150 mM NaCl, 1 mM EGTA, 50 mM sodium fluoride, 1 mM sodium
orthovanadate, 20 M phenylarsine oxide, 1 mM phenylmethylsulfonyl
fluoride, 10 mM iodoacetamide, and a mixture of small peptide protease
inhibitors at 1 g/mL each. All the sucrose solutions were prepared in the
same buffer without detergent and in the presence of small peptide protease
inhibitors at 1 g/mL. Samples were centrifuged for 18 to 20 hours at
200 000g in a Sorvall AH-650 rotor. Eight 0.5-mL fractions were collected
on ice, from the top to the bottom of the gradients. Aliquots of each fraction
(18 L) of the gradient were diluted with 9 L 3  Laemmli sample buffer
and resolved on 12.5% SDS-PAGE under nonreducing conditions, trans-
ferred to PVDF, and immunoblotted with specific antibodies, which
included polyclonal antibodies against DC-SIGN,15 Lck (sc-13; Santa Cruz
Biotechnology), ZAP-70 (sc-574; Santa Cruz Biotechnology), LAT (06-
807; Upstate Biotechnology, Charlottesville, VA), CD3 (A0452; Dako,
Glostrup, Denmark), Syk (AW 1373-13, kindly provided by Dr Arthur
Weiss), Lyn (sc-15; Santa Cruz Biotechnology), ERK (sc-154; Santa Cruz
Biotechnology), cholera toxin–HRP (C4672; Sigma) for ganglioside GM1
detection, or a monoclonal antibody against Ras (RAS10; Upstate Biotech-
nology). In indicated experiments, pools of the sucrose gradient fractions
were collected: the pool of the low-density fractions corresponding to the
5%/30% interface (fractions 2-4) was referred to as rafts; the pool of
fractions 5 and 6 was termed intermediate (intrm.); and the pool of the
high-density soluble material corresponding to fractions 7 and 8 was
referred to as soluble. Cytoskeletal-associated rafts (CARs) were extracted
from the pellet by treatment with 60 mM octyl D-glucoside (ODG) and 1%
Brij 98, and the supernatant was collected after centrifugation at 13 000g.16,17
In indicated experiments, immunoprecipitation under solubilizing condi-
tions was carried out on pooled rafts, intermediate and soluble. Those pools
were diluted with lysis buffer containing 1% Brij 98  60 mM ODG to less
than 20% sucrose.
Immunoprecipitation of protein assemblies was performed by incuba-
tion of these pools with purified monoclonal antibodies against DC-SIGN
(MR-1) or anti-Lyn (sc-7274; Santa Cruz Biotechnology) followed by
capture of the immune complexes on Protein G superparamagnetic
Microbeads (Miltenyi Biotech) as described elsewhere.14 Immunoprecipi-
tates were then subjected to Western blot using polyclonal antibodies
against DC-SIGN (DSG-1),15 Syk (AW 1373-13), Lyn (sc-15), or antiphos-
photyrosine (RC20-HRP). In some experiments, cells were surface-labeled
with biotin. To that end, cells were washed in PBS (pH 8.0) and incubated in
0.5 mg/mL biotinamidohexanoic acid 3-sulfo-N-hydroxysuccinimide ester
sodium salt (B1022; Sigma Aldrich) for 30 minutes at room temperature.
After labeling, cells were extensively washed in PBS, lysed, and subjected
to fractionation by sucrose gradient ultracentrifugation as indicated.14 After
separation, lipid raft–containing and soluble fractions were pooled and
immunoprecipitated with Streptavidin-agarose (Sigma Aldrich), and immu-
noprecipitated material was analyzed by SDS-PAGE and Western blot with
antibodies specific for DC-SIGN or LAT.
Intracellular calcium determination
MDDCs (2.5  106 cells/mL) were resuspended in complete medium and
incubated with Fluo-3AM (Calbiochem, San Diego, CA; 300 M in
DMSO, 10 L/106 cells) for 30 minutes at 37°C. Cells were then washed,
resuspended in RPMI containing 2 mM CaCl2, and maintained at 37°C
before addition of purified anti–DC-SIGN MR-1 monoclonal antibody
(20 g/mL) or an isotype-matched control. Calcium flux was measured in
an EPICS XL flow cytometer at 525 nm (Coulter, Madrid, Spain).
Fluo-3AM loading was controlled using ionomycin as ionophore (5
g/mL). In some experiments SDF-1 (50 mM; Preprotech) was added
before addition of the monoclonal antibody.
Results
DC-SIGN engagement leads to ERK and Akt activation
but does not induce MDDC maturation
To evaluate the signaling capability of DC-SIGN, we initially
assessed the influence of an anti–DC-SIGN antibody on the MDDC
maturation state. Whereas LPS induced MDDC maturation param-
eters (CD83 induction and loss of CD36), purified MR-1 (anti–DC-
SIGN) or HB136 (anti-CD38) antibodies at 20 g/mL (1X) or
60 g/mL (3X) for 24 hours neither altered cell morphology (data
not shown) nor affected the expression of CD83 or CD36 (Figure
1A). Therefore, ligation of DC-SIGN on the cell surface with the
MR-1 antibody does not lead to overt MDDC maturation. How-
ever, cross-linking of DC-SIGN with MR-1 induced a change in the
profile of phosphotyrosine-containing proteins in MDDCs (Figure
1B). The change occurred within 1 minute (data not shown) and
was not further amplified upon cross-linking with a secondary
antibody, which, per se, did not induce any change in the
phosphotyrosine profile (Figure 1B). We reasoned that the ob-
served effect of cross-linking was unlikely to be due to endotoxin
Figure 1. DC-SIGN ligation on MDDCs does not induce maturation but alters the
profile of phosphotyrosine-containing proteins. (A) Immature MDDCs were
isolated and either not stimulated (NS) or treated with lipopolysaccharide (LPS) or
monoclonal antibodies against CD38 (HB136) or DC-SIGN (MR-1) at 20 g/mL (1X)
or 60 g/mL (3X). After 48 hours, cells were collected and the cell surface expression
of CD83 and CD36 was determined by flow cytometry, using an isotype-matched
anti–c-Myc antibody (9E10) as control. The percentage of marker-positive cells and
the mean fluorescence intensity are indicated in each case. Three experiments were
performed on MDDCs from independent donors, and a representative experiment is
shown. (B) DC-SIGN ligation induces changes in the pattern of tyrosine phosphoryla-
tion in MDDCs. Cells were either left untreated (not stimulated, NS) or incubated with
monoclonal antibodies against DC-SIGN (MR-1) as ligation agent, or with MR-1 plus
a cross-linking secondary antibody (anti–mouse F(ab)2, anti–mouse IgG). After 5
minutes, cells were lysed, and the lysates were probed for phosphotyrosine residues
by Western blot using the RC20-HRP monoclonal antibody. As a control, a
monoclonal antibody against c-Myc (anti–c-Myc) was used. Two experiments on
MDDCs from independent donors rendered similar results, and one of them is shown.
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contamination of the antibody, because neither primary nor second-
ary control antibodies alone mimicked the stimulatory effect and
MDDCs exposed to the anti–DC-SIGN antibody did not exhibit
any maturation-specific parameters (Figure 1A).
Analysis of the pattern of tyrosine phosphorylation after
DC-SIGN cross-linking revealed an increased phosphorylation in
the 42 to 50 kDa range, suggesting that ERK1/2 MAP kinases
might be candidate substrate proteins. To determine whether this
was the case, immature MDDCs were treated with MR-1 and
probed for the presence of phosphorylated ERK. DC-SIGN ligation
promoted ERK activation after 5 minutes, whereas an antibody
against CD70 was without effect and antibodies against CD11c
triggered significant ERK phosphorylation only upon cross-linking
with a secondary antibody (Figure 2A). Of interest, further
cross-linking of DC-SIGN with an anti–mouse IgG resulted in
weaker ERK activation (Figure 2A). By contrast, DC-SIGN
ligation did not induce p38 phosphorylation, whereas TNF-
promoted both ERK and p38 activation (Figure 2A).
Kinetic experiments on MDDCs from an independent donor
indicated that DC-SIGN ligation-induced ERK phosphorylation is
a transient event that takes place as early as 1 minute after
stimulation and vanishes after 30 minutes, a time point at which
p38 activation also appears to be diminished by DC-SIGN ligation
(Figure 2B). Moreover, DC-SIGN ligation promoted a weak and
transient activation of PI3K, as evidenced by the appearance of
phosphorylated Akt only 1 minute after stimulation (Figure 2B).
Altogether, these results indicate that antibody ligation of DC-
SIGN on the cell surface of MDDCs induces a wave of intracellular
signaling that results in transient activation of ERK and PI3K, 2
kinases critically involved in dendritic cell maturation.9,18
DC-SIGN engagement was further evaluated for its capacity to
modulate MDDC maturation signals initiated from other cell
surface receptors. To this purpose, we initially focused on TNF-,
which induces maturation markers on MDDCs.19 Whereas TNF-
and DC-SIGN ligation induced ERK activation to a similar extent
(3.5-fold and 5.8-fold increase, respectively, over background
levels), addition of both stimuli to MDDCs resulted in further
enhanced phosphorylation of ERK (to 11.5-fold), whereas the
combination of TNF- and a control antibody did not result in any
enhancement (Figure 2C). Analysis of MDDCs from an indepen-
dent donor produced essentially similar results and indicated
that DC-SIGN cross-linking is capable of inducing ERK phos-
phorylation even in the presence of ultrapure LPS, which failed
to promote significant ERK activation by itself (Figure 2D).
Altogether, these results demonstrate that DC-SIGN is capable
of modulating the intracellular signals originated from matura-
tion-inducing factors.
DC-SIGN engagement triggers intracellular signaling
in myeloid and lymphoid cell lines
Next, we tested whether the signaling capability of DC-SIGN is
restricted to dendritic cells, where it is expressed in very high
levels, or can be observed in other cell types. To that end, DC-SIGN
was engaged with the MR-1 antibody on the surface of THP-1
cells, which exhibit a weak basal level of the lectin (Figure 3A).
Although to a lower extent than in MDDCs, engagement of
DC-SIGN on the surface of THP-1 also resulted in enhanced ERK
activation, which was comparable with the phosphorylation level
induced upon phorbol ester treatment (Figure 3B).
To extend these findings to a different cell lineage, the signaling
ability of DC-SIGN was evaluated in Jurkat-DC-SIGN transfec-
tants, which exhibit a high level of DC-SIGN cell surface
expression (Figure 3C). Like K562 cells,20 Jurkat cells overexpress-
ing DC-SIGN formed large homotypic aggregates (Figure 3D) and
showed rapid lectin down-regulation upon ligation on the cell
Figure 2. DC-SIGN ligation on MDDCs induces ERK phosphorylation and collaborates with TNF-–initiated signals for enhanced ERK activation. (A) Activation of
ERK by DC-SIGN engagement. DC-SIGN on MDDCs was engaged by the anti–DC-SIGN MR-1 antibody and the cells were incubated at 37°C for 5 minutes. For comparison,
cells were treated with the indicated combinations of antibodies or TNF- (20 ng/mL). Following cell lysis, phosphorylated ERK and phosphorylated p38 were detected using
specific polyclonal antisera. Blots were then stripped and probed for -tubulin levels as a control for protein loading (bottom panel). (B) DC-SIGN on MDDCs was engaged by
the anti–DC-SIGN MR-1 antibody, and the cells were incubated at 37°C for the indicated periods of time. For comparison, cells were treated with an antibody against CD70 or
TNF- (20 ng/mL) for 5 minutes. Following cell lysis, phosphorylated ERK, p38, and Akt, and total ERK were detected using specific polyclonal antisera. Blots were then
stripped and probed for -tubulin levels as a control for protein loading. (C-D) Immature MDDCs from 2 independent donors were incubated with an antibody against DC-SIGN
(MR-1) or against CD70, either alone or in combination with TNF- (20 ng/mL) or LPS (10 ng/mL), and the cells were incubated at 37°C for 5 minutes. For comparison, cells
were treated with either LPS (10 ng/mL) or TNF- (20 ng/mL) for 5 minutes. Following cell lysis, phosphorylated ERK (pERK), phosphorylated p38 (pp38), or total ERK content
(ERK) was detected using specific polyclonal antisera. Each experiment was done on MDDCs from at least 4 independent donors, and representative experiments are shown.
In all panels, NS refers to cells that were not stimulated.
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surface (data not shown), thus confirming that DC-SIGN retains its
adhesive and antigen-capture capabilities in Jurkat cells.21 Accord-
ingly, ligation of DC-SIGN in Jurkat cells led to ERK activation but
had no effect on the phosphorylation state of ZAP-70 (Figure 3E)
or p38MAPK (Figure 6A). Therefore, engagement of DC-SIGN on
myeloid (MDDC, THP-1) or lymphoid (Jurkat) results in ERK
phosphorylation.
DC-SIGN is found in lipid-rich regions on the cell surface
of transfected lymphoid cells
Lipid rafts are specialized membrane regions that facilitate out-
side-in signaling by generating a physical environment rich in
kinases, adaptors, and intracellular effectors.22 The ability of
DC-SIGN to trigger intracellular signals prompted us to analyze its
membrane distribution in immature MDDCs and Jurkat-DC-SIGN
cells. In agreement with a previous report,23 analysis of Jurkat-DC-
SIGN transfectants revealed the presence of DC-SIGN in lipid rafts
(Figure 4A). Although DC-SIGN was mainly found in the soluble
fractions, a percentage of the molecules was detected in GM1-rich
lipid rafts, where Lck and LAT, but not ZAP-70, were also detected
(Figure 4A). To examine potential interactions of DC-SIGN with
signaling proteins, DC-SIGN was immunoprecipitated from the
Figure 3. DC-SIGN ligation in myeloid and lymphoid cell lines results in ERK
activation. (A) Cell surface expression of DC-SIGN in THP-1 cells, as determined by
flow cytometry. The percentage of marker-positive cells and the mean fluorescence
intensity are indicated in each case. (B) DC-SIGN on THP-1 cells was engaged by the
anti–DC-SIGN MR-1 antibody (20 g/mL), and the cells were incubated at 37°C for 5
minutes. As a control, cells were either incubated with an anti-CD70 monoclonal
antibody or with PMA (10 ng/mL). After cell lysis, phosphorylated ERK (pERK, top
panel) and total ERK (ERK, middle panel) were detected using specific polyclonal
antisera. The bottom panel illustrates the level of pERK relative to the level of total
ERK under each condition, as determined by densitometric analysis. NS indicates not
stimulated. (C) Cell surface expression of DC-SIGN in mock-transfected (Jurkat) and
DC-SIGN–transfected Jurkat cells (Jurkat-DC-SIGN) as determined by flow cytom-
etry, using an isotype-matched anti–c-Myc antibody (9E10) as control. The mean
fluorescence intensity is indicated in each case. (D) Homotypic aggregation of
mock-transfected (Jurkat) and DC-SIGN–transfected (Jurkat-DCSIGN) Jurkat cells,
as observed by reverse-phase microscopy at 2 different amplifications (5 , 10 ).
(E) DC-SIGN on Jurkat-DC-SIGN transfectants was ligated by the anti–DC-SIGN
MR-1 antibody alone or in the presence of an anti-CD3 monoclonal antibody as
control, and the cells were incubated at 37°C for 1 or 5 minutes. Mock-transfected
Jurkat cells were subjected to the same treatments for control purposes. After cell
lysis, phosphorylated ERK (pERK), phosphorylated ZAP-70 (pZAP-70), and total
content of ERK and ZAP-70 were detected using specific polyclonal antisera. Each
experiment was done 3 times with similar results. Representative results are shown.
Figure 4. DC-SIGN is present within lipid rafts in lymphoid cells and coprecipi-
tates with tyrosine kinases. (A) Jurkat-DC-SIGN (left panels) and mock-transfected
Jurkat cells (right panels) were lysed in 1% Brij 98 lysis buffer at 37°C, and Brij
98–insoluble fractions 2 to 4 (lanes 2-4, rafts) and the high-density Brij 98–soluble
fractions 7 to 8 (lanes 7-8, soluble) were separated by 12.5% SDS-PAGE under
nonreducing conditions. Cytoskeletal-associated rafts (CARs), obtained by solubiliza-
tion of the cell pellet with Brij 98  octyl D-glucoside in lysis buffer, were analyzed in
parallel (lane 9). The distribution of DC-SIGN, Lck, ZAP-70, LAT, CD3, and
ganglioside GM1 in the distinct fractions was determined by immunoblotting with
specific antibodies or cholera toxin–HRP (for GM1). (B) Coprecipitation of DC-SIGN
and tyrosine kinases. DC-SIGN was immunoprecipitated with the MR-1 antibody
(MR1 ip) from lipid raft–containing fractions 2 to 4 (rafts, lane 2), fractions 5 to 6
(between the rafts and the soluble material, lane 3), and the 7 to 8 soluble fractions
(sol., lane 4), and the immunoprecipitated material was subjected to SDS-PAGE and
immunoblotting with antibodies against DC-SIGN, Lck, or ZAP-70. As a control,
fractions containing either rafts (lane 1) or cytoskeletal-associated rafts (CARs, lane
5) were analyzed in parallel. (C) Jurkat-DC-SIGN cells were cell-surface labeled with
biotin, lysed in 1% Brij 98 lysis buffer at 37°C, and Brij 98–insoluble fractions (lanes 1,
rafts), intermediate fractions (lanes 2), high-density Brij 98–soluble fractions (lanes 3,
sol.), and cytoskeletal-associated raft-containing fractions (CARs, lane 4) were
obtained. An aliquot from each fraction was removed and analyzed by 12.5%
SDS-PAGE under nonreducing conditions and subjected to Western blot with
anti–DC-SIGN or anti-LAT polyclonal antisera (left panel). Then, fractions were
subjected to pull-down with Streptavidin-agarose, and the immunoprecipitated
material was separated by 12.5% SDS-PAGE under nonreducing conditions and
subjected to Western blot with anti–DC-SIGN or anti-LAT polyclonal antisera (right
panel). Each experiment was performed twice with similar results, and one of the
experiments is shown.
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distinct membrane fractions in the presence of 1% Brij 98  60
mM octyl D-glucoside (ODG), which efficiently disrupts many
lipid raft–protein associations. As shown in Figure 4B (lane 2), Lck
tyrosine kinase was coimmunoprecipitated with DC-SIGN from
the lipid raft–containing fractions, whereas ZAP-70 was detectable
in DC-SIGN immunoprecipitates from the soluble pool (Figure 4B
lane 4). These results suggest that DC-SIGN can be found in 2
distinct microdomain localizations that differ in their content of
signaling molecules. Next, to determine the microdomain location
of cell surface DC-SIGN, lipid raft–containing and soluble mem-
brane fractions were generated from biotin-labeled Jurkat-DC-
SIGN cells, and the resulting fractions were immunoprecipitated
with Streptavidin-agarose. In agreement with experiments using
unlabeled cell lysates, a large proportion of DC-SIGN was found in
the soluble fraction pool (Figure 4C left panel). However, pull
down of cell surface molecules by immunoprecipitation with
Streptavidin-agarose revealed that most biotin-labeled DC-SIGN
molecules partitioned within the lipid raft– and cytoskeletal-
associated raft-containing fractions (Figure 4C right panel). Densi-
tometric analysis of the results shown in Figure 4C indicated that
80% of the total cell surface expression of DC-SIGN (biotin-
labeled DC-SIGN) is found within the lipid raft–containing frac-
tions. These results indicate that most DC-SIGN molecules on the
cell surface are included in lipid rafts, whereas DC-SIGN mol-
ecules in the soluble fraction pool are not accessible for biotin
labeling and might be contained in intracellular compartments.
DC-SIGN is found in lipid-rich regions on MDDCs
and coprecipitates with tyrosine kinases
To determine the membrane distribution of DC-SIGN in myeloid
cells, detergent-insoluble and -soluble membrane fractions were
isolated from MDDCs. Although a high percentage of the molecule
appeared in soluble fractions, a fraction of DC-SIGN also parti-
tioned within lipid rafts on MDDCs (Figure 5A). Fractionation of
MDDCs from an independent donor further confirmed this DC-
SIGN distribution and revealed that most of the intracellular
membrane-bound tyrosine kinase Lyn partitioned into low-density
fractions 2 to 4, which is consistent with its residency in floating
lipid rafts, whereas the signaling molecules Syk, ERK, and Ras
were partly localized in the lipid-rich regions on MDDCs (Figure
5B). Since DC-SIGN coprecipitates with ZAP-70 and Lck in
lymphoid cells, we next evaluated whether DC-SIGN associated
with related molecules in MDDC membranes. As shown in Figure
5C, DC-SIGN brought down phosphotyrosine-containing mol-
ecules from lipid raft fractions. Moreover, a significant amount of
Lyn and a lesser amount of Syk tyrosine kinases could be detected
in the DC-SIGN precipitates from lipid rafts (Figure 5C), indicat-
ing that DC-SIGN colocalizes with signaling molecules in glyco-
lipid-enriched membranes from MDDCs. Conversely, neither
Syk nor Lyn was detected in DC-SIGN immunoprecipitates from
the soluble membrane fractions, in spite of the fact that DC-SIGN
is more abundant in this fraction (Figure 5C). In addition, analysis
of membrane fractions from an independent MDDC donor demon-
strated the presence of DC-SIGN and Syk in Lyn immunoprecipi-
tates (Figure 5D), further confirming the relationship between
DC-SIGN and these 2 kinases within lipid rafts. However, not all
DC-SIGN molecules are associated to Lyn since DC-SIGN can be
easily pulled down with the MR-1 antibody from the post–anti-Lyn
immunoprecipitation flow-through from either lipid rafts or soluble
membrane fractions (Figure 5E).
Additional intracellular signals initiated
upon DC-SIGN engagement
The maturation state of dendritic cells is a critical parameter that
determines not only whether an immune response is generated but
the type of immune response.2 Besides NF-B activation, other
signaling pathways have an impact on dendritic cell maturation,
including MEK-ERK8 and PI3K9 activation, and transient calcium
increases.24 Given its ability to prompt ERK and Akt phosphoryla-
tion, we tested whether DC-SIGN–initiated signals also affected
intracellular calcium levels. Engagement of DC-SIGN in Jurkat-DC-
SIGN cells triggered PLC-
 phosphorylation, an effect that was not
Figure 5. DC-SIGN is present within lipid rafts in MDDCs and coprecipitates
with Lyn and Syk tyrosine kinases. (A-B) Immature MDDCs from 2 independent
donors were lysed in 1% Brij 98 lysis buffer at 37°C and fractionated by sucrose
density gradient centrifugation as described in “Materials and methods.”14 The
low-density Brij 98–insoluble fractions 2 to 4 (lanes 2-4, rafts) and the high-density
Brij 98–soluble fractions 6 to 8 (lanes 6-8, soluble) were separated by 12.5%
SDS-PAGE under nonreducing conditions, and the distribution of DC-SIGN was
determined by immunoblotting. Cytoskeletal-associated rafts (CARs), obtained by
solubilization of the cell pellet with Brij 98  octyl D-glucoside in lysis buffer, were
analyzed in parallel (lane 9). (A) The left panel was intentionally exposed for longer
than the blot section shown in the right panel. (B) The distribution of Syk, Lyn, ERK,
Ras, and ganglioside GM1 in the distinct fractions was determined by immunoblotting
with specific antibodies or cholera toxin–HRP (for GM1). (C) Coprecipitation of
DC-SIGN, Lyn, and Syk tyrosine kinases. DC-SIGN was immunoprecipitated with the
MR-1 antibody from lipid raft–containing fractions 2 to 4 (rafts), fractions 5 to 6 (intrm.
indicates intermediate between the rafts and the soluble material), and the 7 to 8
soluble fractions (soluble), and the precipitated material was subjected to SDS-PAGE
and immunoblotting with antibodies specific for DC-SIGN, Lyn, Syk, and phosphoty-
rosine-containing proteins. As a control, an aliquot from the whole lysate before
fractionation (WL indicates whole lysate) was analyzed in parallel. (D) Presence of
DC-SIGN and Syk in Lyn immunoprecipitates. Lyn was immunoprecipitated (IP(Lyn))
from the lipid raft–containing fraction pool (rafts) or the soluble material–containing
fraction pool (soluble), and the precipitated material was subjected to SDS-PAGE and
immunoblotting with antibodies specific for Lyn, DC-SIGN, and Syk. As a control,
aliquots from the rafts and soluble fraction pools before immunoprecipitation were
analyzed in parallel. (E) Presence of DC-SIGN in the post–anti-Lyn immunoprecipita-
tion flow-through. Post–anti-Lyn immunoprecipitation flow-through from either lipid
rafts or soluble membrane fraction pools (those indicated in D) were subjected to a
further immunoprecipitation with a monoclonal antibody against DC-SIGN (IP(MR1)),
and the precipitated material was subjected to SDS-PAGE and immunoblotting with a
polyclonal antibody against DC-SIGN (DSG1). As a control, aliquots from the rafts
and soluble fraction pools before immunoprecipitation were analyzed in parallel.
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observed with either anti-CD38 or anti-CD3 antibodies (Figure
6A). In accordance with this finding, DC-SIGN ligation on the
surface of immature MDDCs promoted a transient calcium
mobilization (Figure 6B). Therefore, DC-SIGN engagement on
the cell surface promotes phosphorylation of ERK, Akt, and
PLC-
, and leads to transient changes in intracellular calcium
concentration.
DC-SIGN engagement influences cytokine production
during MDDC maturation
The ability of DC-SIGN to modify the activation state of 3 key
signaling molecules (ERK, Akt, and PLC-
) suggested that DC-
SIGN ligation might exert a modulatory effect on MDDC matura-
tion. Since ERK activation has been linked to Th2-type polariza-
tion and enhanced IL-10 production,11,25 the release of IL-10 in
response to DC-SIGN ligation was determined. Immature MDDCs
did not produce detectable IL-10 in response to either TNF-,
Pam3Cys (a synthetic TLR2 ligand), MR-1 antibody, or a control
mouse IgG, and only LPS was capable of inducing the production
of moderate levels of IL-10 (Figure 7). However, the presence of
MR-1 antibody enhanced LPS-induced IL-10 release (Figure 7).
Moreover, and although each agent alone had no effect, the
simultaneous presence of MR-1 and TNF- resulted in high levels
of IL-10 production (Figure 7). These results are in agreement with
the enhanced ERK phosphorylation observed upon MDDC treat-
ment with anti–DC-SIGN and TNF-, and demonstrate that
DC-SIGN engagement on the membrane of immature dendritic
cells modulates the maturation program initiated by other cell
surface receptors.
Discussion
The generation of pathogen-specific immune responses is based on
the plasticity of the dendritic cell maturation process, which results
from the integration of all the intracellular signals initiated after
recognition of PAMPs by pathogen-recognition receptors. Intracel-
lular signaling from the distinct TLR exhibits the common property
of NF-B activation, but, for DCs, their differential coupling to
adapter molecules, their differential activation of MAPKs, and the
modulation of their signals by other PAMP receptors contribute to
the generation of pathogen-specific dendritic cell maturation and
pathogen-tailored immune responses.25 One of the dendritic cell
PAMP receptors is the C-type lectin DC-SIGN, which participates
in the recognition and capture of numerous viral, bacterial, and
fungal pathogens.3 In the present report, we demonstrate that
DC-SIGN engagement on the dendritic cell surface induces
phosphorylation of ERK and Akt, but not p38MAPK, and promotes
a transient calcium flux, which correlates with its ability to trigger
PLC
 phosphorylation in transfected lymphoid cells. In agreement
with its signaling capability, DC-SIGN in lipid rafts associates with
tyrosine kinases of the Src and Syk/ZAP-70 families in both
dendritic cells and transfected lymphoid cells. All these signaling
events might explain the ability of DC-SIGN–engaging ligands to
shift MDDC maturation toward the acquisition of pro-Th2/
protolerogenic polarizing capability, which is also exemplified by
the fact that DC-SIGN ligation synergizes with TNF- receptor–
initiated signals for enhanced IL-10 release.
The signaling and functional consequences of DC-SIGN liga-
tion here reported are in agreement with the results of Geijtenbeek
et al, who showed that Mycobacterium Man-LAM enhanced IL-10
Figure 6. DC-SIGN ligation results in ERK and PLC- activation in transfected Jurkat cells and promotes transient calcium mobilization in MDDCs. (A) DC-SIGN on
Jurkat-DC-SIGN transfectants was ligated by the anti–DC-SIGN MR-1 antibody, and the cells were incubated at 37°C for 5 minutes. As a control, cells were incubated with
either anti-CD38 or anti-CD3 monoclonal antibodies. Mock-transfected cells were subjected to the same treatments for control purposes. After cell lysis, phosphorylated ERK
(pERK), p38 (pp38), and PLC-
 (pPLC-
), and total levels of ERK and PLC-
were detected using specific polyclonal antisera. The experiment was performed twice with similar
results, and one of the experiments is shown. NS indicates not stimulated. (B-C) Calcium determination in MDDCs after DC-SIGN ligation. Fluo-3AM–loaded MDDCs were left
untreated (B) or treated with 50 nM SDF-1 (C), and subsequently incubated with anti–DC-SIGN MR-1 monoclonal antibody (20 g/mL) (right panel) or an isotype-matched
control antibody (left panel). Calcium flux was determined by flow cytometry at the indicated time points. Arrows indicate the time of addition of the MR-1 monoclonal antibody.
Similar results were obtained from 3 independent experiments, and 1 of them is shown.
Figure 7. DC-SIGN ligation in immature MDDCs enhances
maturation-dependent IL-10 production. MDDCs were incu-
bated with LPS, TNF-, Pam3Cys, MR-1, or an isotype-matched
antibody (IgG), either alone or in the indicated combinations, for
18 hours in complete medium. After incubation, supernatants
from MDDCs were collected and IL-10 content was determined by
enzyme-linked immunosorbent assay (ELISA). The data indicate
means (SD of triplicate samples from 1 representative experiment
of 3 experiments on MDDCs from independent donors).
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production by MDDCs in a DC-SIGN–dependent manner.12 The
comparison of the intracellular signaling pathways activated by
TLR4 and TLR2 has demonstrated that preferential activation of
p38MAPK leads to IL-12p70–dependent pro-Th1 dendritic cell
maturation, while a high ERK/p38MAPK activation ratio promotes
pro-Th2 maturation via increased IL-10 release and reduced
IL-12p70 synthesis.10,11,25 Therefore, the DC-SIGN–mediated ERK
activation fits with the enhanced release of IL-10 seen in maturing
MDDCs after DC-SIGN engagement, and is also compatible with
the inhibitory action of ERK activation on IL-12p70 release by
dendritic cells8 and macrophages.26 Apart from ERK and p38MAPK,
other intracellular signals modulate the pro-Th1/Th2 balance
during MDDC maturation. In this regard, (1) PI3K activation in
dendritic cells has been shown to negatively regulate IL-12
synthesis and, therefore, prevents Th1 polarization27; (2) calcium
signaling antagonizes IL-12 production by mature dendritic cells,
negatively regulates pro-Th1 maturation, and preferentially pro-
motes the acquisition of pro-Th2/Tc2 characteristics24; and (3)
lysophosphatidic acid–induced increase of intracellular calcium
inhibits IL-12 secretion and enhances secretion of IL-10 from
mature dendritic cells.28 Therefore, the intracellular signaling
triggered upon DC-SIGN engagement (ERK and PI3K activation,
transient rise in intracellular calcium concentration) would impair
IL-12 and enhance IL-10 release and, consequently, might explain
why DC-SIGN ligation favors a pro-Th2/protolerogenic dendritic
cell maturation.
The relevance of the DC-SIGN cell surface distribution for
pathogen binding has been previously demonstrated.23 In the
present report, and in line with recent observations,23 biochemical
analysis of MDDC and DC-SIGN transfectants has revealed that a
fraction of DC-SIGN molecules is located within lipid raft–
enriched membrane fractions in both cell types (Figures 4-5) and
that most DC-SIGN molecules on the plasma membrane reside
within lipid raft–enriched microdomains (Figure 4C). Therefore, it
is reasonable to assume that the microlocalization of DC-SIGN on
the plasma membrane should also contribute to its signaling ability.
In this regard, DC-SIGN coprecipitates with Lck or Lyn, 2
Src-family kinases involved in immunoreceptor signaling in lym-
phoid and myeloid cells.29 The colocalization of DC-SIGN, Lyn,
and Syk provides additional structural support for the regulatory
role of DC-SIGN during dendritic cell maturation, as both kinases
have been found to modulate murine dendritic cell maturation.30-32
In fact, Lyn appears to positively regulate IL-12 production in mice
and has been proposed to act as a negative regulator of Th2
immunity.33 Therefore, future experiments are required to deter-
mine the functional significance of the DC-SIGN association with
Lyn and Syk in dendritic cells, as well as to find out whether the
association between DC-SIGN and both kinases reflects direct or
indirect interactions. The latter appears as a likely alternative, given
the lack of an obvious ITAM motif in the DC-SIGN cytoplasmic
tail and the fact that no tyrosine phosphorylation of DC-SIGN has
been detected after engagement by either antibodies or pathogenic
ligands (data not shown).
Besides DC-SIGN, other lectin receptors expressed on myeloid
(Dectin-1) and plasmacytoid (BDCA-2) dendritic cells have been
shown to promote intracellular signaling and to modulate TLR
signaling. Yeast binding to the 	-glucan receptor Dectin-1 syner-
gizes with TLR2 to enhance activation of NF-B and production of
IL-12.34 In addition, Dectin-1 can also promote IL-10 synthesis via
recruitment of Syk to its ITAM motif.35 Similarly to DC-SIGN,
antibody ligation of the plasmacytoid-specific BDCA2 lectin
induces calcium mobilization and protein-tyrosine phosphoryla-
tion, resulting in suppression of IFN-/	 induction by plasmacy-
toid dendritic cells.36 These results, combined with the diversity of
their cytoplasmic sequences, suggest that lectins and lectinlike
receptors expressed on dendritic cells might exhibit a large degree
of variability in the intracellular signaling pathways they activate,
providing an additional level of plasticity for the generation of
pathogen-specific immune responses. In the case of DC-SIGN, the
intracellular signals initiated by this lectin would result in increased
pro-Th2/protolerogenic effector functions and might contribute to
evasion from immunosurveillance of DC-SIGN–interacting patho-
gens.3 However, since mice deficient in the DC-SIGN–related
molecule SIGNR1 exhibit increased susceptibility to Streptococcus
pneumoniae,37 the dissection of the intracellular signals triggered
upon DC-SIGN engagement deserves further investigation, as it
might clarify the role of the lectin family on the generation of
pathogen-specific immune responses.
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